Related Experiment Video
Updated: Aug 14, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis
1University Surgical Unit, Southampton General Hospital, Southampton, UK. c.d.johnson@soton.ac.uk
Platelet-activating factor (PAF) exacerbates acute pancreatitis, leading to organ failure. PAF antagonists, like lexipafant, show promise in reducing inflammation and improving outcomes in severe cases.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Acute pancreatitis involves platelet-activating factor (PAF) release, contributing to systemic complications like circulatory disturbances and organ failure.
- PAF is a key mediator in severe acute pancreatitis, increasing mortality rates and pancreatic damage.
Purpose of the Study:
- To investigate the role of PAF in acute pancreatitis.
- To evaluate the efficacy of PAF antagonists, specifically lexipafant, in managing severe acute pancreatitis.
Main Methods:
- Review of existing literature on PAF's role in acute pancreatitis.
- Analysis of clinical trial data for lexipafant in human acute pancreatitis patients.
Main Results:
- PAF significantly potentiates pancreatic tissue damage and inflammation.
- Lexipafant, a potent PAF receptor antagonist, has demonstrated reductions in organ failure and inflammatory responses in clinical trials.
Conclusions:
- Understanding PAF's central role in severe acute pancreatitis pathology has advanced.
- Clinical confirmation of lexipafant's efficacy could establish it as a novel therapy for severe acute pancreatitis.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction